0001493152-17-003314.txt : 20170331
0001493152-17-003314.hdr.sgml : 20170331
20170331202032
ACCESSION NUMBER: 0001493152-17-003314
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170117
FILED AS OF DATE: 20170331
DATE AS OF CHANGE: 20170331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VBI Vaccines Inc/BC
CENTRAL INDEX KEY: 0000764195
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-830-3031
MAIL ADDRESS:
STREET 1: 222 THIRD STREET
STREET 2: SUITE 2241
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: SciVac Therapeutics Inc.
DATE OF NAME CHANGE: 20150717
FORMER COMPANY:
FORMER CONFORMED NAME: LEVON RESOURCES LTD.
DATE OF NAME CHANGE: 20100910
FORMER COMPANY:
FORMER CONFORMED NAME: LEVON RESOURCES LTD
DATE OF NAME CHANGE: 19850305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILLIS STEVEN
CENTRAL INDEX KEY: 0001229592
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37769
FILM NUMBER: 17732041
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
4
1
form4.xml
X0306
4
2017-01-17
0
0000764195
VBI Vaccines Inc/BC
VBIV
0001229592
GILLIS STEVEN
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS ROAD SUITE 1025
CHICAGO
IL
60631
1
0
0
0
Common Shares, no par value per share
2017-01-17
4
M
0
6377
2.50
A
28166
D
Common Shares, no par value per share
2726057
I
See Footnote
Option (Right to Buy Common Shares)
2.50
2017-01-17
4
M
0
6377
2.50
D
2017-02-06
Common Shares
6377
0
D
Option (Right to Buy Common Shares)
3.79
2017-03-29
4
A
0
15000
0
A
2027-01-26
Common Shares
15000
15000
D
Includes 2,726,057 common shares held of record by ARCH Venture Fund VI, L.P. ("ARCH VI"). ARCH Venture Partners VI, L.P. (the "ARCH GPLP"), as the sole general partner of ARCH VI, may be deemed to beneficially own certain of the shares held of record by ARCH VI. The ARCH GPLP disclaims beneficial ownership of all shares held of record by ARCH VI in which the ARCH GPLP does not have an actual pecuniary interest. ARCH Venture Partners VI, LLC (the "ARCH GPLLC"), as the sole general partner of the ARCH GPLP, may be deemed to beneficially own certain of the shares held of record by ARCH VI. The ARCH GPLLC disclaims beneficial ownership of all shares held of record by ARCH GPLP in which the ARCH GPLLC does not have an actual pecuniary interest. The reporting person owns an interest in ARCH GPLP but does not have voting or investment control over the shares held by ARCH VI and disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The options became fully exercsiable within four months of the grant date of February 6, 2007.
The reporting person is a participant in the Issuer's Incentive Plan (the "Plan"). The board of directors of the Issuer approved the option grant on January 26, 2017 (the "Grant Date"). The options were granted pursuant to that certain option agreement entered into by and between the Issuer and the reporting person, dated March 29, 2017 (the "Option Agreement"). The options vest and become exercisable in 48 equal monthly installments beginning on the first day of the month following the Grant Date.
The options expire 10 years from the Grant Date unless terminated sooner in accordance with the Plan or the Option Agreement.
/s/ Steven Gillis
2017-03-31